• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov14
BTIG Maintains Buy Rating on Ovid, Oppenheimer Cuts to Buy
11:21
Nov13
Ovid Therap released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 132 K (forecast USD 170.38 K), actual EPS USD -0.1709 (forecast USD -0.15)
04:00
Ovid Therap released FY2025 9 Months Earnings on November 12, 2025 (EST) with actual revenue of USD 6.534 M and EPS of USD -0.3772
04:00
Oct27
Ovid Therapeutics Inc. to Hold Special Meeting for Voting on Amending the Restated Certificate of Incorporation Proposal
21:30
Oct9
Analyst Olson Covers Ovid Therapeutics
07:56
Oct3
Minter Analysts Show Good Performance in Recommended Healthcare Stocks
16:46

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 132 K, Net Income -12.16 M, EPS -0.1709

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 6.272 M, Net Income -4.603 M, EPS -0.0647

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 130 K, Net Income -10.06 M, EPS -0.1415

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
VMAR
1.080
+184.16%
+0.700
SRXH
0.5943
+95.17%
+0.289
AMCI
12.940
+77.99%
+5.690
EDHL
0.5650
+48.06%
+0.183
CPAC
10.300
+47.35%
+3.310
RILY
5.095
+36.97%
+1.391
RZLV
3.100
+33.62%
+0.781
VERO
2.205
+32.04%
+0.530
EEX
4.670
+31.92%
+1.130
ALDX
5.120
+28.32%
+1.125
View More